Bio Protocol Don Raise $6.9M to Run AI-Powered DeSci with Bio V2 and Aubrai

Bio Protocol don knack $6.9 million for strategic funding wey Maelstrom Fund lead, with Mechanism Capital, Animoca Brands, and Presto Labs join body. The money wan help make e AI-driven DeSci platform beta by adding on-chain prediction and credit markets, agent communications plus BIO token staking. The new Bio V2 release bring Ignition Sales for tokenized IP, BioXP reward system, and decentralized setups for early research. Every achievement dey record for chain make e dey traceable and contributors fit get recognition. For August 2025, Bio Protocol launch Aubrai, e first BioAgent wey dem develop with VitaDA. Aubrai don raise $900,000, produce over 1,000 blockchain scientific hypotheses, and boost AUBRAI token use. CEO Paul Kohlhaas talk say the platform fit reduce drug discovery time from decades go months. These things show how AI, blockchain, and DeSci dey join body, making Bio Protocol model fit spread research and development power and carry more crypto investors come.
Bullish
Dis funding round and product launches dey show strong momentum for Bio Protocol’s ecosystem. Dem secure $6.9M and deploy Bio V2 with on-chain fundraising, token staking plus live BioAgent (Aubrai) suppose boost investor confidence and token demand for BIO and AUBRAI. Short term, expect make price go up as traders dey react to funding news and new platform features. Long term, the coming together of AI, blockchain and decentralized science fit bring steady growth, wey fit support more interest and higher valuation for DeSci token market.